The KPV peptide mechanism of action is uniquely direct: it enters cells to inhibit NF-κB activation, the master regulator of the inflammatory response. lysine-proline-valine (KPV) tripeptide reaches inflamed gut tissue without requiring surface receptor binding.

Direct NF-κB Pathway Inhibition

KPV inhibits NF-κB by interfering with the IKK complex, preventing pro-inflammatory gene transcription. KPV anti-inflammatory research in the Journal of Investigative Dermatology confirms its cell-penetrating character, distinguishing it from peptides that act only extracellularly.

GI Stability for Intestinal Inflammation

Most peptides are degraded by stomach acid, but KPV's tripeptide structure confers unusual resistance to proteolysis. This allows it to reach the intestinal epithelium intact. In colitis models, it reduces histological inflammation scores and restores barrier integrity directly at the mucosal site.

For researches, KPV's dual-route capability (oral for GI, subcutaneous for systemic) provides a flexible probe for studying delivery-dependent anti-inflammatory efficacy. Beyond Health Lab supplies KPV 10mg at ≥99% verified purity.